Join to view full profile
2330 Shawnee Mission PkwyWestwood, KS 66205
Phone+1 913-588-7750
Dr. Abbasi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Saqib Abbasi, based in Westwood, KS, specializes in oncology with subspecialties in genitourinary oncology and neuro-oncology. His research includes publications on the efficacy of immune checkpoint inhibitors, the impact of cancer metastases on COVID-19 outcomes, and trends in chemotherapy hospitalizations, among others. Dr. Abbasi has contributed to clinical trials, including acting as a principal investigator in a study on avelumab therapy in urothelial carcinoma.
Education & Training
Saba University School of MedicineClass of 2015
Certifications & Licensure
KS State Medical License 2021 - 2027
MO State Medical License 2022 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley) Start of enrollment: 2022 Aug 17
Roles: Principal Investigator
- A Study of IBI363 in Subjects with Advanced Solid Malignancies Start of enrollment: 2024 Apr 08
Roles: Contact
Publications & Presentations
PubMed
- 4 citationsEfficacy and safety of immune checkpoint inhibitors in metastatic penile squamous cell carcinoma: a retrospective multicenter analysis.Timothy Schieber, Kelly Brunk, Anna Clennon, Benjamin L Woolbright, Leonidas E Bantis
Experimental Hematology & Oncology. 2025-03-12 - 4 citationsThe impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.Cecilia A Castellano, Tianyi Sun, Deepak Ravindranathan, Clara Hwang, Nino Balanchivadze
Cancer. 2024-06-15 - 2 citationsImpact of COVID-19 in patients on active melanoma therapy and with history of melanoma.Douglas B Johnson, Michael B Atkins, Cassandra Hennessy, Trisha Wise-Draper, Hannah Heilman
BMC Cancer. 2023-03-23
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: